The Patent Finder

Xintrum Pharmaceuticals, Ltd.

Also on record
Records under this name other than patents Xintrum Pharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Xintrum Pharmaceuticals, Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,220,525Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatography
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,299,548Gene combination capable of high-efficiency expression of recombinant human nerve growth factor
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,443,082Concentration gradient test reagent kit and testing method for use in bacterial/fungal drug susceptibility testing
Lapsed on the fee record
Ended Oct 15, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited